About | Free Trial

Last Update

2009-05-12T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Background Information

Employment History

Chairman and Chief Executive Officer
American BioHealth Group LLC

Chairman and Chief Executive Officer
American Health Group

Web References (22 Total References)


Press Room

www.thehearingpill.com, 31 Oct 2008 [cached]

David Karlman, a San Diego entrepreneur, read about the NAC patent in the Federal Register. Through Tech Link, a federally supported technology transfer office, he began discussions with the Navy.

"My gut told me that this was a good product, considering the market and the incidence of hearing loss in the country," Karlman said.
Then he did due diligence and found there was no therapeutic or preventive agent on the market for hearing loss or related balance disorders.
...
Karlman said the company plans to lobby the government to change this policy in the case of the hearing pill.
Meanwhile, he has licensed another patent from the Navy and signed another development agreement involving the commercialization of NAC in combination with other compounds, which he won't name, for enhanced preventive and restorative properties in hearing loss. These compounds don't have the same clinical history and accumulated safety and efficacy data as NAC, so it's expected to be a longer process.
Karlman won't say how much his company has invested in the hearing pill.
...
Karlman estimates the market for the hearing pill at about $250 million and growing.
He now has competition, including Sound Pharmaceuticals in Seattle, which has a compound that has yet to be tested in humans.
As Karlman moves forward in development of NAC and other compounds, he said he's looking for an established distribution partner that can help the hearing pill gain widespread acceptance.
...
David Karlman Chairman and Chief Executive Officer American BioHealth Group, LLC 15721 Bernardo Heights Parkway Suite 151 San Diego, California 92128 (ph) 858-675-3600 (fax) 858-613-0748
...
suffer from hearing loss due to noise or chemical exposure," said David Karlman, Chairman and Chief Executive Officer of American BioHealth Group, LLC. "Dr.
...
David Karlman Chairman and Chief Executive Officer American BioHealth Group, LLC 15721 Bernardo Heights Parkway Suite 151 San Diego, California 92128 (ph) 858-675-3600 (fax) 858-613-0748
...
stated David Karlman, Chairman and Chief Executive Officer of American BioHealth Group.
...
David Karlman, Chairman and Chief Executive
...
David Karlman Chairman and Chief Executive Officer American BioHealth Group, LLC 15721 Bernardo Heights Parkway Suite 151 San Diego, California 92128 (ph) 858-675-3600 (fax) 858-613-0748
...
Concerning the award of the new license, David Karlman, Chairman and Chief
...
UB, TechLink and others have helped to enable ABG to pursue this exciting path," Karlman
...
David Karlman Chairman and Chief Executive Officer American BioHealth Group, LLC 15721 Bernardo Heights Parkway Suite 151 San Diego, California 92128 (ph) 858-675-3600 (fax) 858-613-0748
...
David Karlman Chairman and Chief Executive Officer American BioHealth Group, LLC 15721 Bernardo Heights Parkway Suite 151 San Diego, California 92128 (ph) 858-675-3600 (fax) 858-613-0748
...
Commenting on the launch of The Hearing Pill, David Karlman, Chairman


David Karlman, a San Diego ...

thehearingpill.com, 29 April 2007 [cached]

David Karlman, a San Diego entrepreneur, read about the NAC patent in the Federal Register.Through Tech Link, a federally supported technology transfer office, he began discussions with the Navy.

"My gut told me that this was a good product, considering the market and the incidence of hearing loss in the country," Karlman said.
Then he did due diligence and found there was no therapeutic or preventive agent on the market for hearing loss or related balance disorders.
...
Karlman said the company plans to lobby the government to change this policy in the case of the hearing pill.
Meanwhile, he has licensed another patent from the Navy and signed another development agreement involving the commercialization of NAC in combination with other compounds, which he won't name, for enhanced preventive and restorative properties in hearing loss.These compounds don't have the same clinical history and accumulated safety and efficacy data as NAC, so it's expected to be a longer process.
Karlman won't say how much his company has invested in the hearing pill.
...
Karlman estimates the market for the hearing pill at about $250 million and growing.
He now has competition, including Sound Pharmaceuticals in Seattle, which has a compound that has yet to be tested in humans.
As Karlman moves forward in development of NAC and other compounds, he said he's looking for an established distribution partner that can help the hearing pill gain widespread acceptance.
...
David KarlmanChairman and Chief Executive OfficerAmerican BioHealth Group, LLC15721 Bernardo Heights Parkway Suite 151San Diego, California 92128(ph) 858-675-3600(fax) 858-613-0748
...
suffer from hearing loss due to noise or chemical exposure," said David Karlman, Chairman and Chief Executive Officer of American BioHealth Group, LLC."Dr.
...
David KarlmanChairman and Chief Executive OfficerAmerican BioHealth Group, LLC15721 Bernardo Heights Parkway Suite 151San Diego, California 92128(ph) 858-675-3600(fax) 858-613-0748
...
stated David Karlman, Chairman and Chief Executive Officer of American BioHealth Group.
...
David Karlman, Chairman and Chief Executive
...
David KarlmanChairman and Chief Executive OfficerAmerican BioHealth Group, LLC15721 Bernardo Heights Parkway Suite 151San Diego, California 92128(ph) 858-675-3600(fax) 858-613-0748
...
Concerning the award of the new license, David Karlman, Chairman and Chief Executive Officer of American BioHealth Group stated, "As American BioHealth
...
UB, TechLink and others have helped to enable ABG to pursue this exciting path," Karlman
...
David KarlmanChairman and Chief Executive OfficerAmerican BioHealth Group, LLC15721 Bernardo Heights Parkway Suite 151San Diego, California 92128(ph) 858-675-3600(fax) 858-613-0748
...
David KarlmanChairman and Chief Executive OfficerAmerican BioHealth Group, LLC15721 Bernardo Heights Parkway Suite 151San Diego, California 92128(ph) 858-675-3600(fax) 858-613-0748
...
Commenting on the launch of The Hearing Pill, David Karlman, Chairman


Naval Medical Center San Diego, and American BioHealth Group Announce Positive Clinical Results on Compound that Protects against Hearing Loss

www.emediawire.com, 22 April 2005 [cached]

David Karlman, Chairman and Chief Executive Officer of American BioHealth Group comments "For the first time millions of individuals have available a safe and clinically proven compound that helps prevent the debilitating damaging effects of common noise exposures.

...
David KarlmanAMERICAN BIOHEALTH GROUPVisit Our Site


TechLink : Biomedicine & Biotechnology : Treating Hearing Loss: New Compounds Show Promise for American BioHealth Group’s Development to Treat or Prevent Hearing Loss

www.techlinkcenter.org, 16 Feb 2005 [cached]

Concerning the award of the new license, David Karlman, Chairman and Chief Executive Officer of American BioHealth Group stated, "As American BioHealth Group expands its portfolio of patented technologies, it is fulfilling its mission to become a leader in developing cutting-edge technology that will address hearing related disorders using safe and unique pharmaceutical approaches. The company is nearing completion of an extensive double blind, placebo controlled, 550+ patient clinical trial and is expected to mark an important milestone toward introducing the first pill clinically proven to prevent hearing loss. Other clinical trials are currently underway as well and more are planned in 2005. "Our research plan is robust and we are confident in our direction and choice of compounds. Our partnering relationships with the Office of Naval Research, the Naval Medical Center San Diego, UB, TechLink and others have helped to enable ABG to pursue this exciting path," Karlman said.

...
David Karlman, Chairman and Chief Executive Officer American BioHealth Group (858) 613-0748 dkarlman@abgpharma.com


TechLink : Biomedicine & Biotechnology : American BioHealth Group Advancing Navy Medical Breakthrough Promising Hearing Loss Restoration and Protection to Millions

www.techlinkcenter.org, 5 Mar 2002 [cached]

"This is a seminal moment for the 39 million plus individuals that are at risk and suffer from hearing loss due to noise or chemical exposure," said David Karlman, Chairman and Chief Executive Officer of American BioHealth Group, LLC.

...
David Karlman, American BioHeath Group, LLC 11808 Rancho Bernardo Road, Ste. 151, San Diego, California 92128

Similar Profiles

Other People with this Name (39)

Other people with the name Karlman

Michael Karlman
NBCUniversal, Inc.

Jenn Karlman
Prana1Media

Judd Karlman
New York Public Library

Kathryn Karlman
Deloitte LLP

Dorris Karlman
Continental Airlines Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory